Elizabeth M. Jaffee, MD,
Elizabeth M. Jaffee, MD, FAACR
President, AACR (2018-2019)
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Elizabeth M. Jaffee, MD, is deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore; associate director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins; the Dana and Albert “Cubby” Broccoli professor of oncology; professor of pathology at the Johns Hopkins University School of Medicine; active staff in oncology at the Johns Hopkins Hospital; associate director for translational research, co-director of gastrointestinal cancer and diseases program, and co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care; and member of the faculty, Graduate Programs in Immunology, Cellular and Molecular Medicine, and Pharmacology, at the Johns Hopkins University School of Medicine.
Jaffee is chair (2016-present) and member (2013-present) of the National Cancer Advisory Board for the National Cancer Institute (NCI) and co-chair of the NCI Blue Ribbon Panel for the National Cancer Moonshot Initiative (2016-present).
An active member of the AACR, Jaffee was elected to the Board of Directors (2013-2016). Her contributions to the AACR have been vast and far-reaching. She is serving as a member of the Organizing Committee of the AACR-LACOG Translational Cancer Medicine Conference in Brazil (2017), and other posts include co-chair (2015, 2017) and member (2006) of the Annual Meeting Program Committee; member of the NextGen Transformative Grants Scientific Review Committee (2015-2017); member of the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Organizing Committee (2015-2016); member of the Publications Committee (2014-2017); member of the Cancer Today Editorial Advisory Board (2014-present); chair (2012-2014) and member (2011, 2012) of the Pancreatic Cancer Action Network-AACR Innovative Grants Scientific Review Committee; deputy editor of the AACR journal Cancer Immunology Research (2012-2015); chair (2012-2013) and member (2009-present) of the Cancer Immunology Working Group; member of the AACR-Princess Takamatsu Memorial Lectureship Award Selection Committee (2012); and co-chair of the Special Conferences “Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances” (2012) and “Tumor Immunology: Basic and Clinical Advances” (2010).
She has also been a member of the AACR Team Science Award Selection Committee (2011-2012, 2015-2017); member of the Tumor Microenvironment Working Group (2009-present); member of the Pancreatic Cancer Research Grants Scientific Review Committee (2009-2010); member of the AACR-Gertrude B. Elion Cancer Research Award Scientific Review Committee (2009); faculty for the Scientist↔Survivor Program at the Annual Meeting (2009); member of the Science Education Committee (2008-2011); co-chair of the Mentored Grants and Research Fellowships Committee (2008); faculty of the educational workshop “Methods in Clinical Cancer Research” (2008, 2009); member of the Annual Meeting Education Committee (2007, 2017); member of the Kirk A. Landon AACR Prize for Basic Cancer Research Selection Committee (2006); member of the Clinical and Translational Cancer Research Committee (2005-2008); faculty of the AACR Educational Workshop “Molecular Biology in Clinical Oncology” (2005); member of the Science Policy and Legislative Affairs Committee (2003-2014); associate editor of Cancer Research (2003-2005); member of the Clinical Cancer Research editorial board (2003-2005); member of the Women in Cancer Research Council; member of the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship Award Selection Committee (2002, 2007); and a member of the Molecular Cancer Therapeutics editorial board (2001-2004).
Jaffee is the leader of the Stand Up To Cancer (SU2C)-Lustgarten Foundation Dream Team: Transforming Pancreatic Cancer to a Treatable Disease. The AACR is the Scientific Partner of SU2C.
Jaffee has received many honors and awards. She was recognized with the AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research (2015), the Johns Hopkins University Office of Women in Science and Medicine Vice Dean’s Award (2012), the Spore Program Investigator of the Year from the NCI (2006), the Director’s Award for Outstanding Teaching from the Johns Hopkins University School of Medicine (1998, 1999, 2001), a Career Development Award from the National Kidney Foundation (1992), and the Physician-Scientist Award from the National Institutes of Health (1992).
Additionally, Jaffee has been a member of the International Society for Biological Therapy of Cancer’s board of directors (2008-2011) and the NCI’s board of scientific counselors (2005-2008).
Jaffee’s previously held positions are: deputy director of the Institute for Translational and Clinical Research at Johns Hopkins University School of Medicine (2007-2015); medical director of the Johns Hopkins Oncology Center, Cell Processing and Gene Therapy Facility (1992-2014); co-director of immunology (2006-2011) and chair of the Clinical Research Committee (2004-2005) at the Sidney Kimmel Comprehensive Cancer Center; associate professor of pathology (1999-2002), associate professor of oncology (1997-2002), and assistant professor of oncology (1992-1997) at Johns Hopkins University School of Medicine.
Jaffee graduated magna cum laude from Brandeis University in Waltham, Massachusetts, and received her medical degree from New York Medical College in Valhalla. For her postdoctoral training, Jaffee was a senior clinical fellow in oncology at the Johns Hopkins Hospital (1989-1992); senior clinical/research fellow in oncology at the Johns Hopkins University School of Medicine (1989-1992); and research fellow (1988-1989), and intern and resident (1985-1988) in the Department of Medicine at the University of Pittsburgh’s Presbyterian-University Hospital. She joined the faculty at Johns Hopkins in 1992.